The Siemens Healthineers SARS-CoV-2 Total Antibody Test will be available on the Atellica Solution immunoassay analyser with an initial time-to-result of 14 minutes. Credit: Business Wire.

Germany’s Siemens Healthineers has developed a laboratory-based total antibody test to identify individuals with past Covid-19 infections.

The test will help to identify the antibodies of SARS-CoV-2, the virus strain that causes the disease, in the individuals who have developed an immune response to the virus.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Currently, Siemens Healthineers is working to receive emergency use authorisation (EUA) from the US Food and Drug Administration (FDA).

The company aims to make the Covid-19 test available by late next month, while its manufacturing facility in Walpole, Massachusetts, US, is expected to deliver more than 25 million tests per month from June.

Siemens Healthineers Laboratory Diagnostics president Deepak Nath said: “Siemens Healthineers is working diligently to address the need for high-quality tests in the fight against Covid-19.

“This test is being designed with the precision and controls, sensitivity and specificity that laboratories have come to expect from our immunoassay tests.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The antibody test will be made available on the Atellica Solution immunoassay analyser. This equipment can run up to 440 tests per hour and will provide a result in approximately 14 minutes.

According to the company, the test is capable of identifying IgM and IgG antibodies and has demonstrated sensitivity and specificity of more than 99%.

Earlier, Abbott Laboratories and Switzerland’s Roche announced a plan to deliver antibody tests.

Abbott aims to deliver 20 million antibody tests per month by June.

Globally, Covid-19 virus has infected more than 2.7 million and nearly 191,000 people have lost their lives due to the pandemic.

Siemens Healthineers launched its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit earlier this month.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact